Formation Bio
Matthew Luppino, MBA, currently serves as a Product Manager and has held various engineering roles at Formation Bio since April 2021, focusing on feature design, technology adoption, and process support. Prior experience includes an Associate Software Engineer position at JPMorgan Chase & Co. within Corporate & Investment Banking Technology, along with multiple technical internships at Fidelity Investments where project leadership and analytical contributions were made. Matthew holds an MBA from NYU Stern School of Business and a Bachelor's Degree in Economics and Computer Science from Duke University.
Formation Bio
5 followers
Formation Bio is a tech-driven pharmaceutical company differentiated by radically more efficient drug development. Formation Bio has built a technology platform that optimizes critical aspects of clinical drug development, enabling more efficient trial design, faster trial completion, and higher quality trial data. The company acquires clinical-stage drugs from pharmaceutical and biotech companies with the goal to develop them faster in order to accelerate access to new treatments for patients, and to unlock greater value per program.